NIH [6/13] | NIH-funded study indicates substantial need to expand access to evidence-based treatment among young people. Only 1 in 4 residential addiction treatment facilities caring for U.S. adolescents under 18 years old offer buprenorphine, a medication used to treat opioid use disorder, according to a new study. Cont.
SAMHSA [12/19] – SAMHSA has issued a new Practical Guide: Advising People on Using 988 Versus 911  to help in better understanding the...
SAMHSA [12/18] – SAMHSA recently published five documents to promote the integration and advancement of promising practices in SUD...
NIDA [12/17] – After declining significantly during the COVID-19 pandemic, substance use among adolescents has continued to hold steady...
Comments